Black-and-white thinking makes people neatly divide their pursuits into extreme categories. Some struggle to see the overlap ...
Esketamine first received FDA approval in 2019, but with an important restriction: it could only be used in combination with an oral antidepressant. That requirement, built into the original label and ...
As biosimilar competition to Johnson & Johnson’s Stelara continues to chew off sales, the much-anticipated launch of the ...
Most weeks when I meet with my therapist, she triages some aspect of my life that is actively bursting at the seams — my ...
Adding as little as 1,700 to 5,500 steps per day can offset the risk of a list of chronic diseases—including obesity, ...
The Hechinger Report reports homelessness among infants and toddlers surged by 23% from 2021 to 2023, impacting nearly ...
Hemab Therapeutics, chaired by former Alnylam chief executive John Maraganore, has published its redacted IPO prospectus with ...
TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime, is the first new FDA-approved ...
Learn how to get an ESA letter for housing in 2026 with RealESAletter's step-by-step guide. Fair Housing Act–compliant, ...
The very phrase "mental health" implies that our emotional life is organised along a continuum of health and illness, like ...
Good morning, and welcome to Johnson & Johnson's First Quarter 2026 Earnings Conference Call. [Operator Instructions] This call is being recorded. [Operator Instructions] I will now turn the call over ...
Depressive symptoms are common in people with asthma, but increasing evidence suggests they may be driven by biological processes that differ from those seen in major depressive disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results